CARMIL2 Immunodeficiency with Epstein Barr Virus Associated Smooth Muscle Tumor (EBV-SMT). Report of a Case with Comprehensive Review of Literature

References

• Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H, Al-Herz W, Chatila T, Crow YJ, Cunningham-Rundles C, Etzioni A, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018 Jan;38(1):129–43. doi:10.1007/s10875-017-0465-8.
   PubMed Web of Science ®Google Scholar
• (a) Roifman CM, Somech R, Kavadas F, Pires L, Nahum A, Dalal I, Grunebaum E. Defining combined immunodeficiency. J Allergy Clin Immunol. 2012 Jul;130(1):177–83. doi:10.1016/j.jaci.2012.04.029. (b) Alazami AM, Al-Helale M, Alhissi S, Al-Saud B, Alajlan H, Monies D, Shah Z, Abouelhoda M, Arnaout R, Al-Dhekri H, Al-Numair NS, Ghebeh H, Sheikh F, Al-Mousa H. Novel CARMIL2 mutations in patients with variable clinical dermatitis, infections, and combined immunodeficiency. Front Immunol. 2018 Feb 9;9:203.
   Google Scholar
• Schober T, Magg T, Laschinger M, Rohlfs M, Linhares ND, Puchalka J, Weisser T, Fehlner K, Mautner J, Walz C, et al. A human immunodeficiency syndrome caused by mutations in CARMIL2. Nat Commun. 2017 Jan23;8:14209. doi:10.1038/ncomms14209.
   PubMed Web of Science ®Google Scholar
• Alazami AM, Al-Helale M, Alhissi S, Al-Saud B, Alajlan H, Monies D, Shah Z, Abouelhoda M, Arnaout R, Al-Dhekri H, et al. Novel CARMIL2 mutations in patients with variable clinical dermatitis, infections, and combined immunodeficiency. Front Immunol. 2018 Feb 9;9:203.
   PubMed Web of Science ®Google Scholar
• Magg T, Shcherbina A, Arslan D, Desai MM, Wall S, Mitsialis V, Conca R, Unal E, Karacabey N, Mukhina A, et al. CARMIL2 deficiency presenting as very early onset inflammatory bowel disease. Inflamm Bowel Dis. 2019 Oct 18;25(11):1788–95. doi:10.1093/ibd/izz103. PMID: 31115454; PMCID: PMC6799948.
   PubMed Web of Science ®Google Scholar
• Yonkof JR, Gupta A, Rueda CM, Mangray S, Prince BT, Rangarajan HG, Alshahrani M, Varga E, Cripe TP, Abraham RS. A novel pathogenic variant in CARMIL2 (RLTPR) causing CARMIL2 deficiency and EBV-associated smooth muscle tumors. Front Immunol. 2020 Jun 18;11:884. doi:10.3389/fimmu.2020.00884. PMID: 32625199; PMCID: PMC7314954.
   PubMed Web of Science ®Google Scholar
• Bosa L, Batura V, Colavito D, Fiedler K, Gaio P, Guo C, Li Q, Marzollo A, Mescoli C, Nambu R, Pan J, et al. Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease. Sci Rep. 2021 Mar 15;11(1):5945. doi:10.1038/s41598-021-85399-9. PMID:33723309; PMCID: PMC7960730.
   PubMed Web of Science ®Google Scholar
• Matsuzaka Y, Okamoto K, Mabuchi T, Iizuka M, Ozawa A, Oka A, Tamiya G, Kulski JK, Inoko H. Identification, expression analysis and polymorphism of a novel RLTPR gene encoding a RGD motif, tropomodulin domain and proline/leucine-rich regions. Gene. 2004 Dec 22;343(2):291–304. doi: 10.1016/j.gene.2004.09.004. PMID: 15588584.
   PubMed Web of Science ®Google Scholar
• Lanier MH, McConnell P, Cooper JA. Cell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2. J Biol Chem. 2016 Jan 15;291(3):1076–91. doi:10.1074/jbc.M115.676882. Epub 2015 Nov 17. PMID: 26578515; PMCID: PMC4714192.
   PubMed Web of Science ®Google Scholar
• Edwards M, Zwolak A, Schafer DA, Sept D, Dominguez R, Cooper JA. Capping protein regulators fine-tune actin assembly dynamics. Nat Rev Mol Cell Biol. 2014 Oct;15(10):677–89. doi:10.1038/nrm3869. Epub 2014 Sep 10. Erratum in: NatRev Mol Cell Biol. 2014 Nov;15(11):701. PMID: 25207437; PMCID: PMC4271544.
   PubMed Web of Science ®Google Scholar
• Lanier MH, Kim T, Cooper JA. CARMIL2 is a novel molecular connection between vimentin and actin essential for cell migration and invadopodia formation. Mol Biol Cell. 2015 Dec 15;26(25):4577–88. doi:10.1091/mbc.E15-08-0552. Epub 2015 Oct 14. PMID: 26466680; PMCID: PMC4678016.
   PubMed Web of Science ®Google Scholar
• Roncagalli R, Cucchetti M, Jarmuzynski N, Grégoire C, Bergot E, Audebert S, Baudelet E, Menoita MG, Joachim A, Durand S, et al. The scaffolding function of the RLTPR ­protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016 Oct 17;213(11):2437–57. doi:10.1084/jem.20160579. Epub 2016 Sep 19. PMID: 27647348; PMCID: PMC5068240.
   PubMed Web of Science ®Google Scholar
• Liang Y, Cucchetti M, Roncagalli R, Yokosuka T, Malzac A, Bertosio E, Imbert J, Nijman IJ, Suchanek M, Saito T, et al. The lymphoid lineage-specific actin-uncapping protein Rltpr is essential for costimulation via CD28 and the development of regulatory T cells. Nat Immunol. 2013 Aug;14(8):858–66. doi:10.1038/ni.2634. Epub 2013 Jun 23. PMID: 23793062.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ma CS, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, Payne K, Crestani E, Roncagalli R, Belkadi A, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016 Oct 17;213(11):2413–35. doi:10.1084/jem.20160576. Epub 2016 Sep 19. PMID: 27647349; PMCID: PMC5068239.
   PubMed Web of Science ®Google Scholar
• Sorte HS, Osnes LT, Fevang B, Aukrust P, Erichsen HC, Backe PH, Abrahamsen TG, Kittang OB, Øverland T, Jhangiani SN, et al. A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction . Mol Genet Genomic Med. 2016 Sep 17;4(6):604–16. doi:10.1002/mgg3.237. PMID: 27896283;PMCID: PMC5118205.
   PubMed Web of Science ®Google Scholar
• Kurolap A, Eshach Adiv O, Konnikova L, Werner L, Gonzaga-Jauregui C, Steinberg M, Mitsialis V, Mory A, Nunberg MY, Wall S, et al. A unique presentation of infantile-onset colitis and eosinophilic disease without recurrent infections resulting from a novel homozygous CARMIL2 Variant. J Clin Immunol. 2019 May;39(4):430–9. doi:10.1007/s10875-019-00631-6. Epub 2019 May 11. PMID: 31079270.
   PubMed Web of Science ®Google Scholar
• Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787–821. doi:10.1146/annurev-immunol-032414-112326. Epub 2015 Feb 11. PMID: 25706097.
   PubMed Web of Science ®Google Scholar
• Deyrup AT. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol. 2008 Apr;39(4):473–83. doi:10.1016/j.humpath.2007.10.030. PMID: 18342658.
   PubMed Web of Science ®Google Scholar
• Arva NC, Schafernak KT. Rare Presentations of Epstein-Barr Virus-Associated Smooth Muscle Tumor in Children. Pediatr Dev Pathol. 2016 Mar-Apr;19(2):132–8. doi:10.2350/15-05-1627-CR.1. Epub 2015 Jul 31. PMID: 26230054.
   PubMed Web of Science ®Google Scholar
• Magg T, Schober T, Walz C, Ley-Zaporozhan J, Facchetti F, Klein C, Hauck F. Epstein-Barr Virus + Smooth Muscle Tumors as Manifestation of Primary Immunodeficiency Disorders. Front Immunol. 2018 Feb 27;9:368. doi:10.3389/fimmu.2018.00368. PMID: 29535735; PMCID: PMC5835094.
   PubMed Web of Science ®Google Scholar
• Tangye SG. Genetic susceptibility to EBV infection: insights from inborn errors of immunity. Hum Genet. 2020 Jun;139(6-7):885–901. doi:10.1007/s00439-020-02145-3. Epub 2020 Mar 9. PMID: 32152698.
   PubMed Web of Science ®Google Scholar
• Cheuk W, Chan JK, Shek TW, Chang JH, Tsou MH, Yuen NW, Ng WF, Chan AC, Prat J. Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol. 2001 Jun;25(6):721–31. doi:10.1097/00000478-200106000-00003. PMID: 11395549.
   PubMed Web of Science ®Google Scholar
• Pritzker KP, Huang SN, Marshall KG. Malignant tumours followingimmunosuppressive therapy. Can Med Assoc J. 1970 Dec 19;103(13):1362–5. PMID:4923839; PMCID: PMC1930644.
   PubMed Web of Science ®Google Scholar
• Chadwick EG, Connor EJ, Hanson IC, Joshi VV, Abu-Farsakh H, Yogev R, McSherry G, McClain K, Murphy SB. Tumors of smooth-muscle origin in HIV-infectedchildren. JAMA. 1990 Jun 20;263(23):3182–4. PMID: 2348529. doi:10.1001/jama.1990.03440230078037.
   PubMed Web of Science ®Google Scholar
• Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med. 1995 Jan 5;332(1):19–25. doi:10.1056/NEJM199501053320104. PMID: 7990861.
   PubMed Web of Science ®Google Scholar
• Hussein K, Rath B, Ludewig B, Kreipe H, Jonigk D. Clinico-pathological characteristics of different types of immunodeficiency-associated smooth muscle tumours. Eur J Cancer. 2014 Sep;50(14):2417–24. doi:10.1016/j.ejca.2014.06.006. Epub 2014 Jul 11. PMID: 25027306.
   PubMed Web of Science ®Google Scholar
• Cheuk W, Li PC, Chan JK. Epstein-Barr virus-associated smooth muscle tumour: a distinctive mesenchymal tumour of immunocompromised individuals. Pathology. 2002 Jun;34(3):245–9. doi:10.1080/00313020220131309. PMID: 12109785.
   PubMed Web of Science ®Google Scholar
• Deyrup AT, Lee VK, Hill CE, Cheuk W, Toh HC, Kesavan S, Chan EW, Weiss SW. Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol. 2006 Jan;30(1):75–82. doi:10.1097/01.pas.0000178088.69394.7b. PMID: 16330945.
   PubMed Web of Science ®Google Scholar
• Dekate J, Chetty R. Epstein-Barr Virus-Associated Smooth Muscle Tumor. Arch Pathol Lab Med. 2016 Jul;140(7):718–22. doi:10.5858/arpa.2015-0120-RS. PMID:27362573.
   PubMed Web of Science ®Google Scholar
• Lau KW, Hsu YW, Lin YT, Chen KT. Role of surgery in treating epstein-barr virus-associated smooth muscle tumor (EBV-SMT) with central nervous system invasion: A systemic review from 1997 to 2019. Cancer Med. 2021Mar;10(5):1473–84. doi:10.1002/cam4.3770. Epub 2021 Feb 11. PMID: 33576167; PMCID: PMC7940242.
   PubMed Web of Science ®Google Scholar
• Penney SW, Bishop BN, Howell DL. Treatment response with sirolimus for a pediatric patient with an EBV-associated smooth-muscle tumor after bone marrow transplantation. Pediatr Blood Cancer. 2019 May;66(5):e27585. doi:10.1002/pbc.27585. Epub 2019 Jan 6. PMID: 30614215.
   PubMed Web of Science ®Google Scholar
• Jonigk D, Laenger F, Maegel L, Izykowski N, Rische J, Tiede C, Klein C, Maecker-Kolhoff B, Kreipe H, Hussein K. Molecular and clinicopathological analysis of Epstein-Barr virus-associated posttransplant smooth muscle tumors. Am J Transplant. 2012 Jul;12(7):1908–17. 2012 Mar 15. PMID: 22420456. doi:10.1111/j.1600-6143.2012.04011.Epub.
   PubMed Web of Science ®Google Scholar
• Ong KW, Teo M, Lee V, Ong D, Lee A, Tan CS, Vathsala A, Toh HC. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications. Clin Cancer Res. 2009 Sep 1;15(17):5350–8. doi: 10.1158/1078-0432.CCR-08-2979. Epub 2009 Aug 25. PMID: 19706821.
   PubMed Web of Science ®Google Scholar
• Jonigk D, Izykowski N, Maegel L, Schormann E, Maecker-Kolhoff B, Laenger F, Kreipe H, Hussein K. MicroRNA expression in Epstein-Barr virus-associated post-transplant smooth muscle tumours is related to leiomyomatous phenotype. Clin Sarcoma Res. 2013 Jul 6;3(1):9 doi:10.1186/2045-3329-3-9. PMID: 23830214;PMCID: PMC3706214.
   PubMedGoogle Scholar
• Jossen J, Chu J, Hotchkiss H, Wistinghausen B, Iyer K, Magid M, Kamath A, Roayaie S, Arnon R. Epstein-Barr virus-associated smooth muscle tumors in children following solid organ transplantation: a review. Pediatr Transplant. 2015 Mar;19(2):235–43. doi:10.1111/petr.12426. Epub 2015 Jan 9. PMID: 25572657.
   PubMed Web of Science ®Google Scholar
• Tan CS, Loh HL, Foo MW, Choong LH, Wong KS, Kee TY. Epstein-Barr virus-associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center. Clin Transplant. 2013 Jul-Aug;27(4):E462–8. doi:10.1111/ctr.12139. Epub 2013 May 20. PMID: 23682851.
   PubMed Web of Science ®Google Scholar
• Parta M, Cuellar-Rodriguez J, Freeman AF, Gea-Banacloche J, Holland SM, Hickstein DD. Resolution of multifocal Epstein-Barr virus-related smooth muscle tumor in a patient with GATA2 deficiency following hematopoietic stem cell transplantation. J Clin Immunol. 2017 Jan;37(1):61–6. doi:10.1007/s10875-016-0360-8. Epub 2016 Dec 6. PMID: 27924436; PMCID: PMC6334651.
   PubMed Web of Science ®Google Scholar
• McLaughlin LP, Bollard CM, Keller MD. Adoptive T cell therapy for Epstein-Barr Virus complications in patients with primary immunodeficiency disorders. Front Immunol. 2018 Mar 19;9:556. doi:10.3389/fimmu.2018.00556. PMID: 29616044;PMCID: PMC5867312.
   PubMed Web of Science ®Google Scholar
• Mierau GW, Greffe BS, Weeks DA. Primary leiomyosarcoma of brain in an adolescent with common variable immunodeficiency syndrome. Ultrastruct Pathol. 1997 May-Jun;21(3):301–5. doi:10.3109/01913129709021926. PMID: 9183831.
   PubMed Web of Science ®Google Scholar
• Tulbah A, Al-Dayel F, Fawaz I, Rosai J. Epstein-Barr virus-associated leiomyosarcoma of the thyroid in a child with congenital immunodeficiency: a case report. Am J Surg Pathol. 1999 Apr;23(4):473–6. doi:10.1097/00000478-199904000-00013. PMID: 10199478.
   PubMed Web of Science ®Google Scholar
• Reyes C, Abuzaitoun O, De Jong A, Hanson C, Langston C. Epstein-Barr virus-associated smooth muscle tumors in ataxia-telangiectasia: a case report and review. Hum Pathol. 2002 Jan;33(1):133–6. doi:10.1053/hupa.2002.30214. PMID:11823985.
   PubMed Web of Science ®Google Scholar
• Monforte-Muñoz H, Kapoor N, Saavedra JA. Epstein-Barr virus-associated leiomyomatosis and posttransplant lymphoproliferative disorder in a child with severe combined immunodeficiency: case report and review of the literature. Pediatr Dev Pathol. 2003 Sep-Oct;6(5):449–57. doi: 10.1007/s10024-003-8096-x. PMID: 14708738.
   PubMed Web of Science ®Google Scholar
• Hatano M, Takada H, Nomura A, Ohga S, Ohshima K, Saeki I, Tajiri T, Taguchi T, Suita S, Hara T. Epstein-Barr virus-associated bronchial leiomyoma in a boy with cellular immunodeficiency. Pediatr Pulmonol. 2006 Apr;41(4):371–3. doi:10.1002/ppul.20375. PMID: 16429426.
   PubMed Web of Science ®Google Scholar
• Atluri S, Neville K, Davis M, Robertson KA, Marshalleck FE, O’Malley DP, Buckley RH, Nelson RP.Jr. Epstein-Barr-associated leiomyomatosis and T-cell chimerism after haploidentical bone marrow transplantation for severe combined immunodeficiency disease. J Pediatr Hematol Oncol. 2007 Mar;29(3):166–72. doi:10.1097/MPH.0b013e31803b95b3. PMID: 17356396.
   PubMed Web of Science ®Google Scholar
• Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, Olivier KN, Spalding C, Hughes S, Pittaluga S, Raffeld M, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010 Feb 25;115(8):1519–29. doi:10.1182/blood-2009-03-208629.
   PubMed Web of Science ®Google Scholar
• Shaw RK, Issekutz AC, Fraser R, Schmit P, Morash B, Monaco-Shawver L, Orange JS, Fernandez CV. Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency. Blood. 2012 Apr 26;119(17):4009–12. doi:10.1182/blood-2011-10-385377.
   PubMed Web of Science ®Google Scholar
• Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher RF, Cabassa P, Facchetti F. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014 Dec;22(8):712–21. doi:10.1177/1066896911399901.
   PubMed Web of Science ®Google Scholar
• Kolukisa B, Baser D, Akcam B, Danielson J, Bilgic Eltan S, Haliloglu Y, Sefer AP, Babayeva R, Akgun G, Charbonnier LM, et al. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency. Allergy. 2021 Jul 20;00:1–16. doi:10.1111/all.15010.
   Google Scholar